Abstract: The invention concerns novel therapeutic uses of heterologous superoxide dismutase (HSD) for preparing medicines for treating diseases in which cell and organic degeneration is observed, and a method for selecting said HSD.
Type:
Grant
Filed:
September 6, 2000
Date of Patent:
July 30, 2002
Assignee:
Fractales Biotech
Inventors:
Bernard Dugas, Alphonse Calenda, Jacques Sauzieres, Eric Postaire